Age-related macular degeneration is a debilitating condition that manifests as a loss of the central portion of an individual's field of vision, affecting 1 in 3 people over the age of 80. With regards to the retina, the organ primarily responsible for an individual's sense of vision, this condition is associated with the degeneration of the central point in the retina, known as the macula, which contains the highest concentration of light-sensitive photoreceptors. It is currently known that the human retina exhibits a gradual decrease in protective detoxifying factors such as glutathione-S-transferase-1 and catalase as well as increased lipid peroxidation, all of which resulting in the age-related increase in autofluorescent lipofuscin between the retina and the choroid. This prevents the proper deliverance of nutrients to the foundational layer of cells in the retina, leading to oxidative stress-related apoptosis of first the retinal pigmented epithelium (RPE) and then the photoreceptors.
Introduction

Anatomy of the Retina
The vertebrate retina is a multilayered structure composed of multiple cell types, including rod and cone photoreceptors, ganglion and amacrine cells, and retinal pigmented epithelium cells (RPEs). These cells are arranged in layers at the back of the eye, forming a complex neural network that allows for the sense of sight. [1] As shown in Figure 1 , this multilayered structure lines the back of the eye between a vascular layer, known as the choroid, and the vitreous gel.
The retina itself is known to be made up of two distinct regions. The neuroretina is composed of various neural cell types such as the rod and cone photoreceptors, amacrine cells and ganglion cells, all of which are collectively responsible for relaying signals generated by light coming into the eye. In this process, light enters the eye through the lens and excites the lightsensitive photoreceptors. These cells then send signals via the amacrine cells to the retinal ganglion cells, whose axons form the optic nerve by which these signals are sent to the brain.
The second region of the retina is known as the pigmented epithelium, which is a layer of cells known as retinal pigmented epithelial cells (RPEs). This layer of cells plays multiple important roles in maintaining the intercellular homeostasis of the neuroretina, including the phagocytosis of outer segments shed by the photoreceptors, [2] maintaining the separation between the neuroretina and the blood supply by the formation of tight junctions, [3] the transfer of ions and other nutrients from the blood supply to the neuroretina, [4] and the conversion and storage of retinoid as part of the visual transduction cycle. [5] Visual impairment can result from damage to the retina from various sources that one may encounter during his or her lifespan. Age-related macular degeneration (AMD) is an example of the lifelong progression in which the accumulation of damage to the retina can coalesce in the loss of sight, which can be a problematic issue with regards to the quality of life in the aging population. There are two types of cells currently under investigation in the context of agerelated retinal degeneration: the light sensitive rod and cone photoreceptors found in the neuroretina and the RPE cells that form the foundation of the retina. Functionally, as previously mentioned, the RPE cells provide structural and nutrient support for the photoreceptors.
Therefore, the pigmented epithelium plays a vital role in the viability of the retina, the degeneration of which would inevitably lead to the degeneration of downstream cells such as the photoreceptors. [6] Age-Related Macular Degeneration: Symptoms and Treatments Age-related macular degeneration (AMD) is a prime example of a neurodegenerative phenomenon, displaying an age-related progression of degeneration in the retina. AMD is the leading cause of vision loss in people over the age of 50 years, affecting approximately 15 million people in the U.S. The condition is characterized by the deterioration of the macula, a portion of the retina that contains the largest concentration of cone photoreceptor cells and is responsible for high resolution vision. There are two main forms of AMD: dry and wet. Wet AMD, the more rare form of AMD, is associated with the resulting retinal detachment due to the formation of new blood vessels in the retina. Dry AMD, which accounts for over 90% of AMD cases, is associated with the age-related build-up of cellular debris between Brusch's membrane and the RPE layer. This accumulation continues with age, leading to the atrophy and eventual death of the pigmented epithelium, ultimately disrupting the cellular homeostasis of downstream retinal cells and eventually cell death of cells in the neuroretina. [7] This progression is outlined in Figure 2 . Symptoms of AMD include the perceived distortion of straight lines, diminished or changed color perception, and dark blurry areas or white-outs that appear at the center of vision. As a result, individuals affected by AMD will present with "reversed tunnel-vision," where they have a blind spot at the center of their field of vision that grows outward with age, as described in the simulation from the National Eye Institute in Figure 3 . Eventually the blind spot will gradually progress outward with age as more retinal cells succumb to the degenerative process.
In the more advanced form of this degeneration, affected individuals will develop the condition known as geographic atrophy (GA), at which point the deterioration completely disrupts the layer of pigmented epithelial cells, leading to legal or complete blindness if a clinical intervention isn't administered. Compared to an individual unaffected by AMD, an AMD patient experiences a blind spot at the center of their field of vision. With age, as retinal cell death accumulates due to increasing cellular stress, this blind spot grows outward. Eventually, without intervention, this phenomenon will result in legal or complete blindness.
To date, there are no treatments that have been shown to effectively halt the degeneration of the retina or rescue vision once cells in the retina have been lost. Therefore, current aims in scientific research are focused on the prevention of this degeneration. With regards to therapeutics, drugs used in the treatment of AMD are VEGF-inhibitors which attempt to halt retinal degeneration through the neovascularization process associated with wet AMD. [8] However, this has no use in the treatment of the dry form of AMD, which doesn't manifest through the neovascularization process. Additionally, VEGF-inhibitor treatments have not been shown to completely rescue the vision of such an affected individual once retinal cells are lost to the degenerative process. Therefore, current strategies that are under scientific investigation include gene therapy and cell-replacement therapy. Although gene therapy has been valued in the treatment of various conditions, the drawback in this case once again lies in its use in late stage AMD. The data presented by Maguire et al. in 2009 shows that the best visual improvements after the use of adeno-associated viruses to restore the functionality of RPE65, a marker of cellular maturity in RPEs, has been seen only in children, whose photoreceptors have not already been lost to the degeneration process. [9] Furthermore, gene therapy is generally most useful in conditions where a loss-of-function mutation is observed or enzyme replacement is necessary, both of which are not the case for AMD and thus have have been shown to exhibit integration and survival after transplantation, even providing a rescue of sight in a Crx-deficient mouse model, albeit to a limited extent. [13] [14] [15] To date, nonmammalian vertebrates have been shown to have the remarkable ability to replace neurons that have been lost by damaging events. [16] [17] [18] However, this phenomenon has yet to be seen to any significant extent in humans. Therefore, despite advances in therapeutic treatments for AMD by cell-replacement strategies, mechanistic studies promise to be invaluable clinical assets in order to elucidate preventative strategies for the retinal degenerative process.
Oxidative Stress as a Key Factor in the Progession of AMD In light of the potential of understanding the mechanisms through which AMD progresses, many investigators focus on defining factors that contribute to the degenerative nature of AMD. From such information, strategies can be developed to help slow or prevent the degenerative process. Current research speculates the beneficial effects of omega-3 fatty acids and various antioxidant molecules in measures to prevent AMD, implicating the role of diet. [19] In one such study, omega-3 fatty acids were shown to have beneficial effects on AMD-like legions in DKO rd8 mice by anti-inflammatory mechanisms of docosahexaenoic acid and eicosapentaenoic acid (EPA). [20] Other environmental factors that have been implicated in the development of AMD include smoking and exposure to smoke, which have been shown to cause systemic oxidative stress, [21, 22] as well as genome instability and DNA damaged caused by exposure to blue and ultraviolet (UV) light. [23] Genetic factors have also been proposed to play a role in the progression of AMD. It has been shown that mutation-induced dysfunctional expression of complement factor H is strongly associated with AMD development through the induction of chronic inflammation, leading to excessive cellular damage to retinal cells. [24, 25] Because the underlying cause of AMD is complex and multifactorial, a single underlying factor that drives the degenerative process is considerably difficult to define. This problem is compounded due to the fact that most animal species lack a macula, therefore finding the appropriate animal model system for in vivo studies is quite difficult. [26] Recent studies have associated oxidative stress as a key element in the progression of AMD, presenting evidence of a decreased expression in glutathione S-transferase-1, increased lipid peroxidation, and a decreasing trend in catalase activity that continues with age. [27] As a result, there is an age-related increase in autofluorescent lipofuscin between the RPE layer and Brusch's membrane.
This substance contains a molecule known as A2E, a pyridinium bisretinoid byproduct of the visual phototransduction pathway. Importantly, A2E is known to be a potent generator of reactive oxygen species (ROS) in the RPE, the accumulation of which can lead to cell death. [28] Therefore, understanding how the RPE reacts, and what pro-survival mechanisms are affected in response to oxidative stress, has potential for further investigations into preventative measures against AMD. One way to investigate cellular response to stress is by focusing on the production of endogenous factors that can play a role in pro-survival mechanisms and how the expression of such factors are affected by cell stress.
One of the most notable signaling pathways that have been associated with oxidative stress response is the NRF2/KEAP1 pathway. This signaling pathway implements cellular responses to oxidative stress through the production of antioxidant response elements (AREs). [29, 30] Under basal conditions, KEAP1 is bound to NRF2, which then directs NRF2 into degradation in the cytosol. However, as visually outlined in Figure 4 , the accumulation of ROS in the event of oxidative stress leads to the dissociation of KEAP1 from NRF2, stabilizing this factor. NRF2 is then translocated into the nucleus where it induces the expression of AREs such as NAD(P)H dehydrogenase quinone 1 (NQO1), heme oxygenase 1 (HMOX1), as well as the catalytic and regulatory subunits of glutamate-cysteine ligase (GCLC and GCLM respectively). As outlined in Figure 5 , the production of mature miRNAs follows a distinctly different pathway from that of functional messenger RNAs. miRNA genes are transcribed by RNA polymerase II to produce a primary miRNA (pri-miRNA) transcript, which is then processed by a microcompressor complex comprised of two factors, DROSHA1 and DGCR8, to produce the pre- 
MicroRNAs in RPE Cells
With regards to the context of retinal cells, past studies highlight the expression and inhibition of miRNAs such as miR204, miR302, [34] miR184, miR187, and miR211 [35] in the maintenance of RPEs. For example, it has been reported that the continuous expression of miR204 and the continuous inhibition of miR302 contributes to the expression of markers such as ZO-1, RPE65, MERTK, and MiTF through the specific targeting of CTNNBIP1, a reported inhibitor of Wnt signaling, and TGFBR2, a factor that aids in the direction of the mesodermal and endodermal cell fates, respectively. [34] Of particular note, it has been shown that miRNAs play a role in RPE cell viability in the pathogenesis of AMD through the dysregulation of protective miRNAs [31] or the accumulation of ALU RNA elements. In both instances, the disease progression has been suggested to be driven by the loss of DICER1, a key protein involved in miRNA biogenesis. [36] Additionally, recent studies have observed shifts in miRNA expression profiles when comparing human ARPE-19 cells that have undergone H 2 O 2 -induced oxidative stress or treatment with the antioxidant curcumin. [37] Although this study involved only acute treatments of H 2 O 2 rather than chronic treatments, which would be a more appropriate experimental design to study AMD with, this indeed suggests the presence of miRNA-dependent pro-apoptotic and anti-apoptotic mechanisms in RPE cells that are activated in response to stress signaling.
Research Focus
As described previously, miRNAs are thought to play a role in how cells react to stress and disease conditions. Data from immortalized cell lines such as ARPE-19 may not accurately and comprehensively represent the disease due to the highly proliferative nature of the cell line's biology. Therefore, RPEs derived from human embryonic stem cells (hESCs) appear to be the ideal candidate for studies on the miRNA profiles of the AMD disease phenotype. Although there have been investigations into miRNA and gene profiling of short-term stress phenotypes,
there has yet to be a comprehensive study looking into such profiling associated with long-term stress with a gradually increasing concentration of stressor, which would be a more appropriate model of AMD. This would be more adequately reflective of the accumulation of lipofuscin products under the RPE layer. Based on previously published methods of deriving retinal cell types from hESCs, including the RPE cell fate [11] our lab seeked to develop a model system displaying the chronically stressed phenotype associated with AMD through paraquat-induced chronic oxidative stress. [38] Once a model system has been developed, changes in miRNA expression can then be monitored by quantitative PCR analysis with modifications designed for the analysis of mature miRNA molecules. [39] This information can then be cross-referenced to the expression profile of protective antioxidant factors such as those found in the NRF2/KEAP1
pathway.
Materials and Methods
Cell Culture and RPE Determination Conditions 
Dichlorofluorescein Assay for ROS generation
To screen for ROS generation at a given time, 2',7'-dichlorofluorescein 3',6'-diacetate (Acros Before transduction of RPE cells, lentivirus-media was filtered through a 0.45µm vacuum-driven filter.
Once filtered, virus-containing media supplemented with polybrene (at a final concentration of 4 µg/mL) was incubated with RPE cells over the course of 2 weeks, with media changes after every 2 days.
Results and Discussion
Establishment of Oxidative Stress Phenotype Reflective of AMD We began this study by the derivation of RPE cells from undifferentiated embryonic stem cells or iPSCs derived from patients affected with Leber's congenital amaurosis, as seen in Figure 6a . These cells were then subjected to treatment with DKK1, noggin, and IGF according to published protocols [11] . After 2-3 weeks of treatment with these factors, clusters of cells exhibiting a cobblestone-like epithelial morphology were manually extracted and transferred into separate culture vessels for proliferation and maturation, resulting in a monolayer of pigmented cells with a uniform morphology, as seen in Figure 6b .
We then conducted experiments to identify sublethal concentrations of hydroquinone and paraquat for the treatment of hESC-RPEs, which would allow us to induce an oxidatively stressed state with RPE cells without the activation of cellular pathways associated with programmed cell death. This will allow us to identify pro-survival molecular pathways involved in the cellular response to stress by PCR under high and low oxidative stress conditions. As noted previously, we also aimed to develop a protocol of oxidative stress induction based on the idea of a gradually accumulating stressor.
With the use of hydroquinone to induce a low stress phenotype, we found that the RPE cells were able to stay alive at 50 µM of hydroquinone for 9 days, seen in Figure 6c at the 1-week time point, and then 100 µM over the next 7 days. In order to induce a high, chronic stress phenotype, we found we were able to use 100 µM of hydroquinone over 9 days, 200 µM over the next 7 days, and then 400 µM over the following day.
In terms of the using paraquat to induce a low stress phenotype, we found that RPE cells were able to stay alive at 20 µM paraquat over 9 days, which is seen in Figure 6e at the 1-week time point, and then at 40 µM over the following 10 days. To induce a high, chronic stress phenotype with paraquat, we were able to use 40 µM of paraquat over 9 days, 80 µM over the next 6 days, and then 160 µM over the following 5 days. Upon further increase in concentration of either hydroquinone or paraquat or time of stressor treatment, RPE cells have often been seen to undergo apoptosis.
With the use of both paraquat and hydroquinone, we were able to observe a change in the traditional cobblestone-like morphology of RPE cells. Although this is less pronounced in the use of paraquat, we have noted that these cells take on a more elongated morphology reminiscent of fibroblasts, which we believe indicates an extent of an epithelial-tomesenchymal transition which is reflective of the proliferative characteristics of RPE cells. We were able to then validate the generation of ROS associated with the incubation with oxidant stressor by DCF staining of intracellular ROS, as seen in Figure 7 . Once an observable phenotype was seen in cells treated with oxidative stressors, we sought a means to measure this phenotype through the analysis of pro-survival mechanisms. We elected to check for the activity of the NRF2/KEAP1 pathway, a pathway known to play a significant role in the production of endogenous antioxidant response elements (AREs) in lieu of stress signaling. As seen in Figure 8a and 8b, both paraquat and hydroquinone were able to induce the production of downstream products of the NRF2/KEAP1 pathway, including GCLC, GCLM, HMOX1, and NQO1 by at least a 4-fold increase compared to untreated RPE control cells.
Interestingly, we also found that P21, a factor associated with cell cycle arrest and anti-proliferative conditions [41] is also upregulated with stressor treatment. Additionally, p21 has been shown to stabilize NRF2 by competitive binding, preventing KEAP1 from binding to NRF2.
This ultimately prevents the KEAP1-induced ubiquitination of NRF2 and therefore promotes a pro-survival oxidative stress response. [42] We have also been able to confirm the translocation of NRF2 into the nucleus and therefore the induction of endogenous antioxidant element expression by immunostaining, as seen Figure 8c and 8d.
Next, we looked for potential miRNA candidates that may exhibit significant change in expression due to oxidative stress signaling. Through various publications, we found a number of potential miRNA candidates that may play a role in oxidative stress signaling as well as cancer pathology. This list of miRNAs include miR200a [43] , miR27b [44] , miR23b [45] , miR146a [46] , miR29a [47] , miR29b [48] , miR143 [49] , miR144 [50] . As seen in Figure 9a and 9b, various miRNAs such as miR27b, miR29b1, miR302c, miR126, and miR146a are upregulated by at least a 4-fold difference with a lower concentration of paraquat, and miR200a, miR27b, miR23a, miR144, miR149, and miR27a are upregulated by a similar amount. Both profiles suggest a negative regulatory effect on gene mRNA transcripts, which may in fact play a role in the survival of RPEs in light of an oxidant stressor. As seen in Figure 9c and 9d, various miRNAs such as miR20a, miR29b1, miR29a, miR302c, and miR146a are upregulated under chronic oxidative stress conditions with a higher concentration of hydroquinone. Interestingly, there are increases in the expression of miR146a and miR29a under chronic oxidative stress conditions with a higher concentration of paraquat, along with a rather striking decrease in miR144. This suggests a dramatic upregulation in the gene targets associated with miR144-target UTR binding. Based on the data described above, we next sought to directly assess the effects of the manipulation of miRNA expression on the induction of an oxidative stress phenotype and RPE survival. With regards to inhibiting miRNA expression, we specifically focused on two miRNAs, miR27b and miR29b using a lentivirus-mediated expression method to express miRNA decoy Because of the marked decrease in miR144 expression in high stress conditions, we also sought to asses the effects of miR144 overexpression on the oxidative stress response implemented by RPEs in high stress conditions. To address this question, we induced the elevated expression of miR144 as well as a scrambled, non-silencing miRNA construct in a separate culture, both via lentivirus-mediated expression in hESC-RPEs. As seen in Figure 11a , when compared to hESC-RPEs expressing a non-silencing miRNA construct, cells expressing heightened levels of miR144 displayed slightly elevated expression of antioxidant response elements when treated with 320 µM paraquat for 1 week, particularly of HMOX1 and NQO1 by approximately a 0.5-fold change. However, with regards to miRNA expression, the elevated expression of miR144 with a similar stress treatment has been seen to induce the elevation of miR27a and miR29a, which further points to the hypothesis that the expression of miRNAs involved in a similar cellular function are affected by a change in the expression of one of the miRNAs involved. In this case, a pro-survival change in miRNA expression induced the elevated expression of miRNA27a and miRNA29a both of which have been shown to play a role in stress conditions.
Conclusion
The etiology of AMD is one with an exceptionally complex nature. It is one that researchers find difficult to define due to a lack of a good model system when the limitations presented by immortalized cell lines and animal models are taken into consideration. In this study, we have generated an in vitro disease model using human embryonic stem cell-derived RPE cells that we believe reflects the nature of age-related macular degeneration using a protocol that allows us to observe the oxidative stress phenotype using time-dependent increases in stressor concentration. Using this model, we have been able to observe changes in miRNA expression of miRNAs such as miR144, miR29b1, miR29a, miR27b, and miR23a, which have previously been implicated in cancerous conditions. Additionally, these microRNAs exhibit changes in expression between low, short-term stress and high chronic stress, suggesting miRNA-based mechanisms for immediate and long-term stress response for the purpose of maintaining cellular homeostasis, as outlined in the heatmaps presented in Figure 12 . We have also been able to correlate these findings with enhanced expression of products found in the NRF2/KEAP1 pathway. Interestingly, previously published publications indicate the anti-cancer role of NRF2/KEAP1 activity through cytoprotection against oxidant damage. [50] This, when taken into account the heightened expression of miRNAs such as miR29a and miR29b1, which have been speculated to have DNA-demethylating and anti-tumor capacities [48, 50] , may indicate an anti-proliferative, antioxidant-associated mechanism used as a defense against cell death. However, further studies involving the expression of gene transcripts associated with cancer will have to be performed in order to further elucidate a causal mechanism of action for such miRNAs which may play a role in pro-survival conditions in light of oxidative stress.
Of additional note, we have been able to make a preliminary observation of the effects of stress-related miRNA inhibition by the inhibition of miR27b and miR29b through the use of a decoy construct. We have also been able to note the effects of elevated stress-associated miRNA expression through the overexpression of miR144, which led to the increase in the expression of miR27a and miR29a, additional miRNAs implicated in RPE stress response. These observations suggest a mechanism of inter-miRNA communication as seen in current research, [50] where the inhibition of one miRNA affects the expression of various other related miRNAs which may play a role in biological mechanisms such as redox homeostasis. Further investigation will have to be performed in order to determine the role of factors that promote the repression of such miRNAs and then elucidate a mechanism portraying a regulatory network of stress-related miRNAs. However, such observations noted in this study suggest a promising potential in the role of miRNAs with regards to regulatory mechanisms that govern the response of RPE cells to chronic oxidative stress. This provides a new level of insight as well as potential target molecules of interest in studies involving the progression of AMD.
